Equity Profile

SYK

Stryker Corporation

Health CareHealth Care Equipment$130.8B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Stryker Corporation (SYK) is a leading medical technology company that develops and manufactures innovative medical devices and equipment. Operating in the health care sector, Stryker plays a crucial role in improving patient outcomes through its advanced products in areas such as surgical equipment, orthopedic implants, and neurotechnology.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health, which investors closely monitor.

$3.68

Revenue

Total revenue reflects the company's sales performance and growth, providing insight into market demand for its products.

$6.7B

Wall Street expectations, options signals, track record, and call prep available with Pro.

SYK Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+0.54%

Avg Stock Reaction

-0.54%

Last Quarter Recap

In Q1-2026, Stryker reported an EPS of $2.60, which was below the expected $2.98, leading to a surprise of -12.63%. The stock remained unchanged the following day, indicating a cautious market reaction.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Stryker to report improved earnings in Q2-2026, with a consensus EPS of $3.68. Investors are looking for signs of recovery after a disappointing Q1.

Bull Case

If Stryker beats EPS estimates and shows strong revenue growth, it could signal a rebound in demand for its medical devices, boosting investor confidence.

Bear Case

Conversely, if the company fails to meet expectations again, it may raise concerns about its market position and growth prospects, leading to a negative reaction.

Key Metrics to Watch

EPS

$3.68

Earnings per share is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue

$6.7B

Total revenue reflects the company's sales performance and growth, providing insight into market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Stryker's EPS exceed the consensus estimate of $3.68?

A beat on EPS would indicate stronger profitability and could help restore investor confidence after the last quarter's miss.

What insights will management provide regarding revenue growth and demand trends?

Understanding revenue growth and market demand is crucial for assessing the company's recovery trajectory and future performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus expects a recovery based on historical trends, but Stryker's recent performance suggests that underlying demand may not be as strong as anticipated.

Supporting Evidence

The last quarter's significant EPS miss indicates potential ongoing challenges in sales.

Options pricing suggests a limited expected move, which may not account for the volatility seen in recent quarters.

Key Risk

If revenue growth fails to meet the expected $6.7B, it could undermine the bullish outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it follows a disappointing Q1, and investors are keenly watching for signs of improvement.

Bull Confirmed If

Achieving an EPS of $3.75 or higher would confirm the bull case and indicate a strong recovery.

Bear Confirmed If

An EPS below $3.50 would support the bear case, raising concerns about ongoing challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±1.09%

Historical Avg

±0.8%

Pricing rich

The options market is pricing in a modest move of about 1.09% in either direction following the earnings report.

Options are pricing ±1.1% while SYK has averaged ±0.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

33.6%

Calls (73K)P/C Ratio: 2.01Puts (54K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Stryker beats expectations, history suggests the stock could see a modest increase, confirming a positive turnaround narrative.

In-Line / Cautious

If results are in line with expectations, the stock may react neutrally, reflecting ongoing caution among investors.

Miss

Should Stryker miss again, history indicates a potential decline in stock value, as investors may lose confidence in the company's growth prospects.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on sales.
2Management's commentary on market demand in key segments like orthopedics and neurotechnology.
3Insights into cost management strategies and their effect on margins.
4Discussion on competitive pressures and how Stryker plans to address them.
5Any guidance on future earnings expectations or market conditions.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

KRCAMC

Kilroy Realty Corporation

PreviewView

Jul27

PIIAMC

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health, which investors closely monitor.

$3.68

Revenue

Total revenue reflects the company's sales performance and growth, providing insight into market demand for its products.

$6.7B

Wall Street expectations, options signals, track record, and call prep available with Pro.

SYK Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+0.54%

Avg Stock Reaction

-0.54%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Stryker to report improved earnings in Q2-2026, with a consensus EPS of $3.68. Investors are looking for signs of recovery after a disappointing Q1.

Bull Case

If Stryker beats EPS estimates and shows strong revenue growth, it could signal a rebound in demand for its medical devices, boosting investor confidence.

Bear Case

Conversely, if the company fails to meet expectations again, it may raise concerns about its market position and growth prospects, leading to a negative reaction.

Key Metrics to Watch

EPS

$3.68

Earnings per share is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue

$6.7B

Total revenue reflects the company's sales performance and growth, providing insight into market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Stryker's EPS exceed the consensus estimate of $3.68?

A beat on EPS would indicate stronger profitability and could help restore investor confidence after the last quarter's miss.

What insights will management provide regarding revenue growth and demand trends?

Understanding revenue growth and market demand is crucial for assessing the company's recovery trajectory and future performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus expects a recovery based on historical trends, but Stryker's recent performance suggests that underlying demand may not be as strong as anticipated.

Supporting Evidence

The last quarter's significant EPS miss indicates potential ongoing challenges in sales.

Options pricing suggests a limited expected move, which may not account for the volatility seen in recent quarters.

Key Risk

If revenue growth fails to meet the expected $6.7B, it could undermine the bullish outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it follows a disappointing Q1, and investors are keenly watching for signs of improvement.

Bull Confirmed If

Achieving an EPS of $3.75 or higher would confirm the bull case and indicate a strong recovery.

Bear Confirmed If

An EPS below $3.50 would support the bear case, raising concerns about ongoing challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±1.09%

Historical Avg

±0.8%

Pricing rich

The options market is pricing in a modest move of about 1.09% in either direction following the earnings report.

Options are pricing ±1.1% while SYK has averaged ±0.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

33.6%

Calls (73K)P/C Ratio: 2.01Puts (54K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Stryker beats expectations, history suggests the stock could see a modest increase, confirming a positive turnaround narrative.

In-Line / Cautious

If results are in line with expectations, the stock may react neutrally, reflecting ongoing caution among investors.

Miss

Should Stryker miss again, history indicates a potential decline in stock value, as investors may lose confidence in the company's growth prospects.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on sales.
2Management's commentary on market demand in key segments like orthopedics and neurotechnology.
3Insights into cost management strategies and their effect on margins.
4Discussion on competitive pressures and how Stryker plans to address them.
5Any guidance on future earnings expectations or market conditions.